These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 16631535

  • 1. Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.
    Drel VR, Pacher P, Stevens MJ, Obrosova IG.
    Free Radic Biol Med; 2006 Apr 15; 40(8):1454-65. PubMed ID: 16631535
    [Abstract] [Full Text] [Related]

  • 2. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
    Obrosova IG, Pacher P, Szabó C, Zsengeller Z, Hirooka H, Stevens MJ, Yorek MA.
    Diabetes; 2005 Jan 15; 54(1):234-42. PubMed ID: 15616034
    [Abstract] [Full Text] [Related]

  • 3. Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.
    Drel VR, Pacher P, Ali TK, Shin J, Julius U, El-Remessy AB, Obrosova IG.
    Int J Mol Med; 2008 Jun 15; 21(6):667-76. PubMed ID: 18506358
    [Abstract] [Full Text] [Related]

  • 4. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose.
    Liu W, Liu P, Tao S, Deng Y, Li X, Lan T, Zhang X, Guo F, Huang W, Chen F, Huang H, Zhou SF.
    Arch Biochem Biophys; 2008 Jul 15; 475(2):128-34. PubMed ID: 18471986
    [Abstract] [Full Text] [Related]

  • 5. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.
    Obrosova IG, Drel VR, Pacher P, Ilnytska O, Wang ZQ, Stevens MJ, Yorek MA.
    Diabetes; 2005 Dec 15; 54(12):3435-41. PubMed ID: 16306359
    [Abstract] [Full Text] [Related]

  • 6. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
    Drel VR, Xu W, Zhang J, Pavlov IA, Shevalye H, Slusher B, Obrosova IG.
    Endocrinology; 2009 Dec 15; 150(12):5273-83. PubMed ID: 19854869
    [Abstract] [Full Text] [Related]

  • 7. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
    Drel VR, Xu W, Zhang J, Kador PF, Ali TK, Shin J, Julius U, Slusher B, El-Remessy AB, Obrosova IG.
    Invest Ophthalmol Vis Sci; 2009 Apr 15; 50(4):1778-90. PubMed ID: 19098320
    [Abstract] [Full Text] [Related]

  • 8. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.
    Shevalye H, Stavniichuk R, Xu W, Zhang J, Lupachyk S, Maksimchyk Y, Drel VR, Floyd EZ, Slusher B, Obrosova IG.
    Biochem Pharmacol; 2010 Apr 01; 79(7):1007-14. PubMed ID: 19945439
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Biochemical Evidence Indicates the Preventive Effect of Resveratrol and Nicotinamide in the Treatment of STZ-induced Diabetic Cataract.
    Singh A, Bodakhe SH.
    Curr Eye Res; 2021 Jan 01; 46(1):52-63. PubMed ID: 32631099
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease.
    Shevalye H, Maksimchyk Y, Watcho P, Obrosova IG.
    Biochim Biophys Acta; 2010 Nov 01; 1802(11):1020-7. PubMed ID: 20621183
    [Abstract] [Full Text] [Related]

  • 14. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of periodontitis in diabetes.
    Adachi K, Miyajima SI, Nakamura N, Miyabe M, Kobayashi Y, Nishikawa T, Suzuki Y, Kikuchi T, Kobayashi S, Saiki T, Mizutani M, Ohno N, Noguchi T, Mitani A, Matsubara T, Naruse K.
    J Clin Periodontol; 2017 Oct 01; 44(10):971-980. PubMed ID: 28570002
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy.
    Obrosova IG, Li F, Abatan OI, Forsell MA, Komjáti K, Pacher P, Szabó C, Stevens MJ.
    Diabetes; 2004 Mar 01; 53(3):711-20. PubMed ID: 14988256
    [Abstract] [Full Text] [Related]

  • 17. Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats.
    Ghahary A, Luo JM, Gong YW, Chakrabarti S, Sima AA, Murphy LJ.
    Diabetes; 1989 Aug 01; 38(8):1067-71. PubMed ID: 2526763
    [Abstract] [Full Text] [Related]

  • 18. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}.
    Drel VR, Lupachyk S, Shevalye H, Vareniuk I, Xu W, Zhang J, Delamere NA, Shahidullah M, Slusher B, Obrosova IG.
    Endocrinology; 2010 Jun 01; 151(6):2547-55. PubMed ID: 20357221
    [Abstract] [Full Text] [Related]

  • 19. Nitrosative stress, protein tyrosine nitration, PARP activation and NAD depletion in the kidneys of rats after single dose of cyclophosphamide.
    Abraham P, Rabi S.
    Clin Exp Nephrol; 2009 Aug 01; 13(4):281-287. PubMed ID: 19266253
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.